In The News :: Can-Fite BioPharma Ltd. (CANF)

Feb 22, 2021

Can-Fite BioPharma's Namodenoson Improves Liver Function, Long Term Data Shows

Feb 19, 2021

Piclidenoson From Can-Fite Biopharma Shows New, Promising Developments For Psoriasis

Dec 4, 2018

Muscle Tissue’s Resistance to Cancer Could Hold Key to New Treatment

May 4, 2015

THERAPEUTIC FOCUS - Adenosine Receptors – The Promise of A3AR Research

Jan 2, 2015

Can-Fite moves towards opening Phase 3 study of adenosine A3 receptor agonist, CF101 in rheumatoid arthritis

Sep 1, 2014

Treating Plaque Psoriasis: A Novel Oral Anti-Inflammatory Agent

Aug 27, 2014

New Data Show High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients

Aug 22, 2014

Healing the Skin from Within? New Approach may Bring Needed Help for Sufferers

Aug 6, 2014

Psoriasis, RA Drug Shows Good Efficacy

Jul 28, 2014

Can-Fite Biopharma CEO, Dr. Pnina Fishman, talks about the role of CF101 in treating psoriasis